Template:Boxes

From 2013.igem.org

(Difference between revisions)
Line 5: Line 5:
<div id="leftcontent" style="background:-webkit-gradient(linear, left top, left bottom, from(#c35617), to(#fbb117));  
<div id="leftcontent" style="background:-webkit-gradient(linear, left top, left bottom, from(#c35617), to(#fbb117));  
background: -moz-linear-gradient(top, #f2f2f2, #f8f8f8); color:#333333; height:150px;">
background: -moz-linear-gradient(top, #f2f2f2, #f8f8f8); color:#333333; height:150px;">
-
<p style="line-height:140%; padding-left:10px; padding-top:10px; padding-right:10px;text-align:justify; font-size:90%;"> Team NRP-UEA-Norwich iGEM 2013 are developing a biosensor that will enable the identification of novel antimycin-producing strains of streptomycetes. Antibiotic resistance is a rapidly growing global problem and is being exacerbated by the failure to discover new antibiotics. Modified antimycins could be effective anti-cancer drugs. Building up a library of antimycin gene clusters will broaden known pathway (biosynthetic) diversity with the foresight of facilitating genetic engineering. In the long term, pathways could be engineered to create new variants of antimycin with unique or enhanced properties.</p>
+
<p style="line-height:140%; padding-left:10px; padding-top:10px; padding-right:10px;text-align:justify; font-size:90%;"> Team NRP-UEA-Norwich iGEM 2013 are developing a biosensor that will enable the identification of novel antimycin-producing strains of streptomycetes. Building up a library of antimycin gene clusters will broaden known pathway (biosynthetic) diversity with the foresight of facilitating genetic engineering. In the long term, pathways could be engineered to create new variants of antimycin with unique or enhanced properties.</p>
</div>
</div>
</div>
</div>

Revision as of 10:11, 28 June 2013

Team NRP-UEA-Norwich iGEM 2013 are developing a biosensor that will enable the identification of novel antimycin-producing strains of streptomycetes. Building up a library of antimycin gene clusters will broaden known pathway (biosynthetic) diversity with the foresight of facilitating genetic engineering. In the long term, pathways could be engineered to create new variants of antimycin with unique or enhanced properties.

For our Human Practices we wanted to find out whether Synthetic Biology was feared and the reasons behind whether it was feared or if people were welcoming of this new scientific discipline. Click on the link above to find out more..

This year the UEA/JIC iGEM team was proud to host the Annual iGEM UK conference. The meet up provided a great opportunity to find out how other teams were progressing and the kinds of directions their projects were taking. The meet up also provided an unmissable opportunity to socialise and to fully engage in the spirit of iGEM. Click on the link above to find out more.